Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Myrtle has various health benefits and potential for medicine development.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Genes and hormones cause hair loss, with four genes contributing equally.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

New compounds may soon be tested to treat excessive hair growth in women.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.